Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 6Phase 1/2 6Phase 1 5Phase EARLY_PHASE1 2Phase 4 1

Status

Completed 6

Sponsor Class

OTHER 3NIH 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Melanoma 7Kidney Neoplasms 6Carcinoma, Renal Cell 6Leukemia 4Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Congenital Abnormalities 2Burkitt Lymphoma 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hodgkin Disease 1

Interventions

Interferon-alpha 7aldesleukin 6Sunitinib 6Radiotherapy 5Nivolumab 5Doxorubicin 5Vincristine 4Ipilimumab 4Filgrastim 4Dactinomycin 4Chemotherapy, Adjuvant 4Axitinib 4cabozantinib 3Sorafenib 3Everolimus 3Etoposide 3Cyclophosphamide 3temsirolimus 2pembrolizumab 2Ifosfamide 2G250 monoclonal antibody 2Fluorouracil 2Carboplatin 2Bevacizumab 2vitespin 1shark cartilage extract 1pazopanib 1lenvatinib 1glutamic acid diethyl ester 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Kidney Neoplasms × aldesleukin × Clear all
NCT00003126 2017-01-04

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer

Loyola University

Phase 3 Completed
69 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00053820 2013-12-19

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 3 Completed
670 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00018941 2013-06-17

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00416429 2012-09-26

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Centre Leon Berard

Phase 3 Completed
456 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00416871 2012-09-26

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

Centre Leon Berard

Phase 3 Completed
220 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00053807 2012-09-24

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
96 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡